Hopp til innhold
NHI.no
Annonse

Churg-Strauss syndrom: Prognose

Eosinofil granulomatose med polyangiitt er en alvorlig sykdom. Tidligere var dette en tilstand som de fleste døde av, men moderne behandling har endret dette vesentlig. De aller fleste som får behandling, vil bli helbredet. Derfor er det svært viktig at du gjennomfører behandlingen nøyaktig og i samråd med lege.

Annonse

Selv om sykdommen blir kurert av behandlingen, er det forholdsvis mange av pasientene som ikke blir kvitt astmaen. Denne kan imidlertid som regel behandles med vanlige astmamedisiner.

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Eosinofil granulomatose med polyangiitt (Churg-Strauss) . Referanselisten for dette dokumentet vises nedenfor

  1. King TE. Clinical features and diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss). UpToDate, last updated Feb 15, 2018. UpToDate
  2. Groh M, Pagnoux C, Baldini C, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. Eur J Intern Med. 2015;26:545-553. PubMed
  3. Sinico RA, Bottero P. Churg-Strauss angiitis. Best Pract Res Clin Rheumatol 2009; 23:355. PubMed
  4. Ntatsaki E, Carruthers D, Chakravarty K, et al; BSR and BHPR Standards, Guidelines and Audit Working Group. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology (Oxford). 2014;53:2306-2309. PubMed
  5. Bibby S, Healy B, Steele R, et al. Association between leukotriene receptor antagonist therapy and Churg-Strauss syndrome: an analysis of the FDA AERS database. Thorax 2010; 65:132. PubMed
  6. Pagnoux C, Guillevin L. Churg-Strauss syndrome: evidence for disease subtypes? Curr Opin Rheumatol 2010; 22:21. PubMed
  7. Comarmond C, Pagnoux C, Khellaf M, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum 2013; 65:270. PubMed
  8. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 1951; 27: 277-301. PubMed
  9. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990; 33: 1094-100. PubMed
  10. Cottin V, Bel E, Bottero P, et al. Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Autoimmun Rev 2017; 16:1. PubMed
  11. King TE. Treatment and prognosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss). UpToDate, last updated Jun 23, 2020. UpToDate
  12. Bel EH, Wenzel SE, Thompson PJ, et al. Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma. N Engl J Med 2014; 371: 1189-97. doi:10.1056/NEJMoa1403291 DOI
  13. Ortega HG, Liu MC, Pavord ID, et al. Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma. N Engl J Med 2014; 371: 1198-1207. doi:10.1056/NEJMoa1403290 DOI
Annonse
Annonse